Biote (BTMD) Change in Accured Expenses (2021 - 2026)

Biote has reported Change in Accured Expenses for 6 years, with the latest figure at $256000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 109.61% year-over-year to $256000.0; the trailing twelve-month figure through Mar 2026 stood at $178000.0 (down 94.34% YoY), and the FY2025 full-year result was -$2.7 million, down 159.22% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $256000.0, up from -$1.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $4.9 million in Q3 2023, with the low at -$26.1 million in Q2 2022.
• Average Change in Accured Expenses over 5 years is -$1.6 million, with a median of -$826000.0 recorded in 2023.
• Year-over-year, Change in Accured Expenses plunged 32986.68% in 2022 and surged 358.59% in 2024.
• Tracing BTMD's Change in Accured Expenses over 5 years: stood at $555000.0 in 2022, then sank by 421.08% to -$1.8 million in 2023, then surged by 358.59% to $4.6 million in 2024, then slumped by 127.6% to -$1.3 million in 2025, then surged by 120.13% to $256000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $256000.0 (Q1 2026), -$1.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison